Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Immunotherapy Combined With Humanized Monoclonal Anti-IgE Antibody Xolair® (Omalizumab)in the Treatment of Cow's Milk Allergy

NCT01157117 is registered in ClinicalTrials.gov with Hugh A Sampson, MD as lead sponsor.

NCT NCT01157117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01157117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Immunotherapy Combined With Humanized Monoclonal Anti-IgE Antibody Xolair® (Omalizumab)in the Treatment of Cow's Milk Allergy
Lead sponsor
Hugh A Sampson, MD
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
October 31, 2015
Enrollment
77 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

milk allergy